Literature DB >> 27045028

Role of Bile Acid-Regulated Nuclear Receptor FXR and G Protein-Coupled Receptor TGR5 in Regulation of Cardiorenal Syndrome (Cardiovascular Disease and Chronic Kidney Disease).

Moshe Levi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27045028      PMCID： PMC5291829          DOI： 10.1161/HYPERTENSIONAHA.115.06417

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  30 in total

Review 1.  Cardio-Pulmonary-Renal Interactions: A Multidisciplinary Approach.

Authors:  Faeq Husain-Syed; Peter A McCullough; Horst-Walter Birk; Matthias Renker; Alessandra Brocca; Werner Seeger; Claudio Ronco
Journal:  J Am Coll Cardiol       Date:  2015-06-09       Impact factor: 24.094

Review 2.  Chronic kidney disease and worsening renal function in acute heart failure: different phenotypes with similar prognostic impact?

Authors:  Alberto Palazzuoli; Carlo Lombardi; Gaetano Ruocco; Margherita Padeletti; Ranuccio Nuti; Marco Metra; Claudio Ronco
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2015-06-04

3.  Farnesoid X receptor activation prevents the development of vascular calcification in ApoE-/- mice with chronic kidney disease.

Authors:  Shinobu Miyazaki-Anzai; Moshe Levi; Adelheid Kratzer; Tabitha C Ting; Linda B Lewis; Makoto Miyazaki
Journal:  Circ Res       Date:  2010-04-29       Impact factor: 17.367

4.  Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes.

Authors:  Gregory Proctor; Tao Jiang; Mieko Iwahashi; Zhuowei Wang; Jinping Li; Moshe Levi
Journal:  Diabetes       Date:  2006-09       Impact factor: 9.461

Review 5.  Chronic kidney disease and cardiovascular complications.

Authors:  Luca Di Lullo; Andrew House; Antonio Gorini; Alberto Santoboni; Domenico Russo; Claudio Ronco
Journal:  Heart Fail Rev       Date:  2015-05       Impact factor: 4.214

6.  G Protein-Coupled Bile Acid Receptor TGR5 Activation Inhibits Kidney Disease in Obesity and Diabetes.

Authors:  Xiaoxin X Wang; Michal Herman Edelstein; Uzi Gafter; Liru Qiu; Yuhuan Luo; Evgenia Dobrinskikh; Scott Lucia; Luciano Adorini; Vivette D D'Agati; Jonathan Levi; Avi Rosenberg; Jeffrey B Kopp; David R Gius; Moin A Saleem; Moshe Levi
Journal:  J Am Soc Nephrol       Date:  2015-09-30       Impact factor: 10.121

7.  Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation.

Authors:  Mitsuhiro Watanabe; Sander M Houten; Chikage Mataki; Marcelo A Christoffolete; Brian W Kim; Hiroyuki Sato; Nadia Messaddeq; John W Harney; Osamu Ezaki; Tatsuhiko Kodama; Kristina Schoonjans; Antonio C Bianco; Johan Auwerx
Journal:  Nature       Date:  2006-01-08       Impact factor: 49.962

8.  Functional characterization of the semisynthetic bile acid derivative INT-767, a dual farnesoid X receptor and TGR5 agonist.

Authors:  Giovanni Rizzo; Daniela Passeri; Francesca De Franco; Gianmario Ciaccioli; Loredana Donadio; Giorgia Rizzo; Stefano Orlandi; Bahman Sadeghpour; Xiaoxin X Wang; Tao Jiang; Moshe Levi; Mark Pruzanski; Luciano Adorini
Journal:  Mol Pharmacol       Date:  2010-07-14       Impact factor: 4.436

9.  Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model.

Authors:  Xiaoxin X Wang; Tao Jiang; Yan Shen; Yupanqui Caldas; Shinobu Miyazaki-Anzai; Hannah Santamaria; Cydney Urbanek; Nathaniel Solis; Pnina Scherzer; Linda Lewis; Frank J Gonzalez; Luciano Adorini; Mark Pruzanski; Jeffrey B Kopp; Jill W Verlander; Moshe Levi
Journal:  Diabetes       Date:  2010-08-10       Impact factor: 9.461

Review 10.  Mouse models of diabetic nephropathy.

Authors:  Frank C Brosius; Charles E Alpers; Erwin P Bottinger; Matthew D Breyer; Thomas M Coffman; Susan B Gurley; Raymond C Harris; Masao Kakoki; Matthias Kretzler; Edward H Leiter; Moshe Levi; Richard A McIndoe; Kumar Sharma; Oliver Smithies; Katalin Susztak; Nobuyuki Takahashi; Takamune Takahashi
Journal:  J Am Soc Nephrol       Date:  2009-09-03       Impact factor: 10.121
View more
  5 in total

Review 1.  The Role of Gut Microbiota in Atherosclerosis and Hypertension.

Authors:  Junli Ma; Houkai Li
Journal:  Front Pharmacol       Date:  2018-09-25       Impact factor: 5.810

Review 2.  Role of Gut Microbiota and Their Metabolites on Atherosclerosis, Hypertension and Human Blood Platelet Function: A Review.

Authors:  Asim K Duttaroy
Journal:  Nutrients       Date:  2021-01-03       Impact factor: 5.717

3.  Myocardial Infarction and Coronary Artery Disease in Menopausal Women With Type 2 Diabetes Mellitus Negatively Correlate With Total Serum Bile Acids.

Authors:  Xunxun Feng; Guangyao Zhai; Jiaqi Yang; Yang Liu; Yujie Zhou; Qianyun Guo
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-05       Impact factor: 5.555

4.  Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression.

Authors:  Hua Chen; Gang Cao; Dan-Qian Chen; Ming Wang; Nosratola D Vaziri; Zhi-Hao Zhang; Jia-Rong Mao; Xu Bai; Ying-Yong Zhao
Journal:  Redox Biol       Date:  2016-09-28       Impact factor: 11.799

Review 5.  Gut microbiota derived metabolites in cardiovascular health and disease.

Authors:  Zeneng Wang; Yongzhong Zhao
Journal:  Protein Cell       Date:  2018-05-03       Impact factor: 14.870
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.